JP2025032110A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025032110A5 JP2025032110A5 JP2024196799A JP2024196799A JP2025032110A5 JP 2025032110 A5 JP2025032110 A5 JP 2025032110A5 JP 2024196799 A JP2024196799 A JP 2024196799A JP 2024196799 A JP2024196799 A JP 2024196799A JP 2025032110 A5 JP2025032110 A5 JP 2025032110A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- seq
- protein
- capsid protein
- aav capsid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025085876A JP2025119015A (ja) | 2019-05-24 | 2025-05-22 | 改変ウイルス粒子およびその使用 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962852791P | 2019-05-24 | 2019-05-24 | |
| US62/852,791 | 2019-05-24 | ||
| PCT/US2020/034328 WO2020242984A1 (en) | 2019-05-24 | 2020-05-22 | Modified viral particles and uses thereof |
| JP2021569402A JP2022533438A (ja) | 2019-05-24 | 2020-05-22 | 改変ウイルス粒子およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569402A Division JP2022533438A (ja) | 2019-05-24 | 2020-05-22 | 改変ウイルス粒子およびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025085876A Division JP2025119015A (ja) | 2019-05-24 | 2025-05-22 | 改変ウイルス粒子およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025032110A JP2025032110A (ja) | 2025-03-11 |
| JP2025032110A5 true JP2025032110A5 (enExample) | 2025-06-02 |
Family
ID=71094822
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569402A Pending JP2022533438A (ja) | 2019-05-24 | 2020-05-22 | 改変ウイルス粒子およびその使用 |
| JP2024196799A Pending JP2025032110A (ja) | 2019-05-24 | 2024-11-11 | 改変ウイルス粒子およびその使用 |
| JP2025085876A Pending JP2025119015A (ja) | 2019-05-24 | 2025-05-22 | 改変ウイルス粒子およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569402A Pending JP2022533438A (ja) | 2019-05-24 | 2020-05-22 | 改変ウイルス粒子およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025085876A Pending JP2025119015A (ja) | 2019-05-24 | 2025-05-22 | 改変ウイルス粒子およびその使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20220241430A1 (enExample) |
| EP (1) | EP3976631A1 (enExample) |
| JP (3) | JP2022533438A (enExample) |
| KR (1) | KR20220011664A (enExample) |
| CN (2) | CN113874386A (enExample) |
| AR (2) | AR118997A1 (enExample) |
| AU (1) | AU2020283537A1 (enExample) |
| BR (1) | BR112021023692A2 (enExample) |
| CA (1) | CA3140386A1 (enExample) |
| CL (2) | CL2021003096A1 (enExample) |
| CO (1) | CO2021017692A2 (enExample) |
| IL (1) | IL288233A (enExample) |
| MA (1) | MA56035A (enExample) |
| MX (1) | MX2021014338A (enExample) |
| PE (1) | PE20212357A1 (enExample) |
| PH (1) | PH12021552887A1 (enExample) |
| SG (1) | SG11202112917PA (enExample) |
| TW (1) | TW202110869A (enExample) |
| WO (1) | WO2020242984A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021516048A (ja) | 2018-02-28 | 2021-07-01 | ユニバーシティ オブ ピッツバーグ −オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 遺伝子及びタンパク質の送達のためのａａｖに基づくモジュールシステム |
| CN113874386A (zh) * | 2019-05-24 | 2021-12-31 | 瑞泽恩制药公司 | 经修饰的病毒颗粒和其用途 |
| WO2022187377A1 (en) * | 2021-03-02 | 2022-09-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Adeno-associated viruses and methods and materials for making and using adeno-associated viruses |
| US20250195693A1 (en) * | 2021-04-30 | 2025-06-19 | Duke University | Compositions Comprising Adeno-Associated Virus Chimera Capsid Proteins and Methods of Using the Same |
| AU2022296534A1 (en) * | 2021-06-23 | 2024-01-25 | Dyno Therapeutics, Inc. | Capsid variants and methods of using the same |
| JP2025516527A (ja) | 2022-05-09 | 2025-05-30 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | インビボ抗体産生のためのベクター及び方法 |
| WO2023240124A1 (en) | 2022-06-07 | 2023-12-14 | Regeneron Pharmaceuticals, Inc. | Pseudotyped viral particles for targeting tcr-expressing cells |
| WO2025042462A2 (en) * | 2023-08-24 | 2025-02-27 | Ohio State Innovation Foundation | Assays and methods for quality control of genome packaging for gene therapy |
| TW202528546A (zh) * | 2023-09-07 | 2025-07-16 | 美商再生元醫藥公司 | 經共價表面修飾之腺相關病毒的生產及純化 |
| US20250163468A1 (en) * | 2023-11-21 | 2025-05-22 | Regeneron Pharmaceuticals, Inc. | Covalently surface modified adeno-associated virus production by in vitro conjugation, and purification of covalently surface modified adeno-associated virus |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU727531B2 (en) | 1995-07-25 | 2000-12-14 | Crucell Holland B.V. | Methods and means for targeted gene delivery |
| CA2265460A1 (en) | 1996-09-11 | 1998-03-19 | The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services | Aav4 vector and uses thereof |
| US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
| ES2313784T3 (es) * | 1998-05-28 | 2009-03-01 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Vector aav5 y usos del mismo. |
| ATE362542T1 (de) | 1998-11-05 | 2007-06-15 | Univ Pennsylvania | Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten |
| NZ618298A (en) * | 2001-11-13 | 2015-04-24 | Univ Pennsylvania | A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| EP2158211B1 (en) | 2007-05-31 | 2016-08-10 | Medigene AG | Mutated structural protein of a parvovirus |
| SMT201900251T1 (it) | 2009-12-10 | 2019-07-11 | Regeneron Pharma | Topi che producono anticorpi della catena pesante |
| GB201002362D0 (en) | 2010-02-11 | 2010-03-31 | Isis Innovation | Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds |
| CN105163764B (zh) * | 2013-03-15 | 2019-11-12 | 北卡罗来纳-查佩尔山大学 | 双重聚糖结合aav载体的方法和组合物 |
| MX385339B (es) * | 2014-03-10 | 2025-03-18 | Uniqure Ip Bv | Vectores aav mejorados adicionales producidos en células de insecto. |
| CA3124228C (en) | 2014-03-21 | 2024-05-14 | Regeneron Pharmaceuticals, Inc. | Non-human animals that make single domain binding proteins |
| WO2015191508A1 (en) * | 2014-06-09 | 2015-12-17 | Voyager Therapeutics, Inc. | Chimeric capsids |
| ES2943020T3 (es) | 2017-06-27 | 2023-06-08 | Regeneron Pharma | Partículas virales recombinantes con tropismo modificado y usos de las mismas para la introducción selectiva de material genético en células humanas |
| MD3645551T2 (ro) | 2017-06-27 | 2024-08-31 | Regeneron Pharma | Vectori virali recombinanţi modificați cu tropism și utilizările acestora pentru introducerea țintită a materialului genetic în celulele umane |
| CN113874386A (zh) * | 2019-05-24 | 2021-12-31 | 瑞泽恩制药公司 | 经修饰的病毒颗粒和其用途 |
-
2020
- 2020-05-22 CN CN202080038612.3A patent/CN113874386A/zh active Pending
- 2020-05-22 BR BR112021023692A patent/BR112021023692A2/pt unknown
- 2020-05-22 SG SG11202112917PA patent/SG11202112917PA/en unknown
- 2020-05-22 TW TW109117155A patent/TW202110869A/zh unknown
- 2020-05-22 MX MX2021014338A patent/MX2021014338A/es unknown
- 2020-05-22 AR ARP200101465A patent/AR118997A1/es unknown
- 2020-05-22 AU AU2020283537A patent/AU2020283537A1/en active Pending
- 2020-05-22 MA MA056035A patent/MA56035A/fr unknown
- 2020-05-22 PE PE2021001934A patent/PE20212357A1/es unknown
- 2020-05-22 JP JP2021569402A patent/JP2022533438A/ja active Pending
- 2020-05-22 CN CN202210622571.3A patent/CN114989267A/zh active Pending
- 2020-05-22 PH PH1/2021/552887A patent/PH12021552887A1/en unknown
- 2020-05-22 WO PCT/US2020/034328 patent/WO2020242984A1/en not_active Ceased
- 2020-05-22 EP EP20733099.4A patent/EP3976631A1/en active Pending
- 2020-05-22 US US17/612,669 patent/US20220241430A1/en active Pending
- 2020-05-22 KR KR1020217041074A patent/KR20220011664A/ko active Pending
- 2020-05-22 CA CA3140386A patent/CA3140386A1/en active Pending
-
2021
- 2021-11-18 IL IL288233A patent/IL288233A/en unknown
- 2021-11-19 AR ARP210103220A patent/AR124119A2/es unknown
- 2021-11-23 CL CL2021003096A patent/CL2021003096A1/es unknown
- 2021-12-22 CO CONC2021/0017692A patent/CO2021017692A2/es unknown
-
2023
- 2023-03-03 CL CL2023000629A patent/CL2023000629A1/es unknown
-
2024
- 2024-11-11 JP JP2024196799A patent/JP2025032110A/ja active Pending
-
2025
- 2025-05-22 JP JP2025085876A patent/JP2025119015A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025032110A5 (enExample) | ||
| Levine et al. | Peptide functionalized nanoparticles for nonviral gene delivery | |
| US9951329B2 (en) | Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles | |
| FI3645553T3 (fi) | Tropismilla muokattuja rekombinantteja viruspartikkeleita ja niiden käyttöjä geneettisen materiaalin viemiseksi kohdennetusti ihmissoluihin | |
| US9302014B2 (en) | Cell-penetrating peptides having a central hydrophobic domain | |
| US12297433B2 (en) | Targeted trans-splicing using CRISPR/Cas13 | |
| KR20240113624A (ko) | Aav 캡시드 변이체 및 이의 용도 | |
| FI4211231T3 (fi) | Peptidimodifioitu aav-kapsidi | |
| JP2014504150A5 (enExample) | ||
| JP2010533170A (ja) | 化合物を種々の選択された臓器、組織又は腫瘍細胞に標的化するための分子 | |
| WO2012142659A1 (en) | Site-selective modification of proteins | |
| US20220282276A1 (en) | Chemically-modified adeno-associated virus | |
| JPWO2020223236A5 (enExample) | ||
| AU2014267044A1 (en) | Bacteriophage | |
| US20230340496A1 (en) | Aptamer template and method for preparing aptamer by using same | |
| JP7705672B2 (ja) | 核酸多量化を介した多価タンパク質薬物およびワクチンの構築方法と適用 | |
| JP2023506635A (ja) | Ｎ－アセチルガラクトサミン結合ポリペプチドを含むｍＲＮＡ標的化分子およびその調製方法 | |
| JP7697656B2 (ja) | 人工ウイルスキャプシド | |
| JPWO2022119871A5 (enExample) | ||
| KR20220117091A (ko) | 생체내 세포에서 합성 및 분비되고 세포로 투과하는 관심 폴리펩타이드를 코딩하는 발현카세트 및 이의 용도 | |
| CN118556069A (zh) | 用于穿透血脑屏障的肽及其用途 | |
| US20250376664A1 (en) | Virus-Ribonucleoprotein Conjugates | |
| WO2014030147A2 (en) | Synthetic proteins based on dendrimers | |
| WO2025084336A1 (ja) | Ａａｖのキャプシドと標的受容体に同時に結合することができる分子 | |
| WO2025042711A1 (en) | Engineered transferrin receptor binding peptides as well as methods of making and using the same |